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INTRODUCTION AND AIM OF DIPLOMA THESIS 
 
It is fact that one of the significant sectors of the economy with many strategic 
benefits, which are identified either in the sense of mature capabilities either in the sense of 
good times and potential growth prospects is the pharmaceutical industry and  more 
specifically, the production sector of pharmaceutical and chemical products for medical 
purposes.  
However, it should be noted that there is a direct function of the industry with the 
applied pharmaceutical and insurance policy, given the particular nature of the drug as 
good with particular social characteristics.  
The aim of this book is to provide information about the Greek pharmaceutical 
legislation and the duties and responsibilities of pharmacists in Greece as compared to 
those in Czech Republic. It also focuses on the chambers of pharmacists and the reason 
they were organized. The book refers not only to community pharmacies, but also to 




CHAPTER 1: Health system in Greece 
1.1 General information about Greece 
Greece, officially the Hellenic Republic, is a country in Southern Europe.It is 
located near the crossroads of Europe and Asia, Greece forms the southern extremity of the 
Balkan peninsula in south-east Europe.With an area of 131,940 square kilometers(50.942 
square miles)
40)
, Greece is a land of mountains and sea. Its territory includes more than 2 
000 islands in the Aegean and Ionian seas, of which only around 165 are inhabited. 
According to 2010 census, Greece’s population is around 10,815,197(see picture 1 
below). Athens is the national capital and largest city(in 2012 it was estimated about 3,75 
millions of people). 
 







The country consists of nine geographic regions: Macedonia, Central Greece, the 
Peloponnese, Thessaly, Epirus, the Aegean Islands(including Dodecanese and Cyclades), 
Thrace, Crete, and the Ionian Islands. 
Modern Greece has a republican structure based on the constitution of 1975. The 
300 members of the single-chamber parliament are elected for a period of four years. The 
country is divided into 13 administrative regions. 
Moreover Greece is member of eurozone since 2001. It is one of the cradles of 
European civilisation, whose ancient scholars made great advances in philosophy, 
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medicine, mathematics and astronomy. Their city-states were pioneers in developing 
democratic forms of government. The historical and cultural heritage of Greece continues 
to resonate throughout the modern world - in literature, art, philosophy and politics. 
Modern Greece has a republican structure based on the constitution of 1975. The 
300 members of the single-chamber parliament are elected for a period of four years. The 
country is divided into 13 administrative regions. 
1.2National health system 
Social insurance is compulsory and all citizens are protected. There are three 
systems: the system of social insurance for the protection of employees, the system of 
social welfare which provides care for people in need, and the national health system 
which covers all persons resident in Greek territory. 
From the administrative standpoint, the social insurance system is coordinated and 
supervised mainly by the Ministry of Labour and Social Insurance, and the health and 
welfare systems are coordinated by the Ministry of Health and Social Solidarity. 
The social insurance system seeks to cover the risks faced by employees by 
granting benefits and services which make up for reduction or loss of income from 
employment. The system encompasses main and supplementary public insurance and 
functions through autonomous insurance bodies. 
Organisations involved 
The general body for the social insurance of employed persons is the Social 
Insurance Institute (IKA). 
Persons with their own business and professionals are insured by the Self-
Employed Professionals’ Insurance Organisation. 
The Agricultural Insurance Organisation provides insurance cover for the entire 
farming population. 











The Greek national health system is operated by the Social Insurance Institute 
(I.K.A). It is necessary to obtain a health booklet from your local IKA office as soon as 
you start work. The booklet has to be presented on all visits to a doctor or hospital. At the 
same time you will be given a social insurance number (ΑΜΚΑ)). The local IKA office 
will provide a list of doctors who work within the national health system. All medical care 
is free, but there is a prescription charge equal to 25 percent of the cost of medicines. 
Free emergency treatment is provided for EU visitors/employment seekers, who 
should bring with them the European Health Insurance Card from the country of origin. 
Public servants, bank employees, traders and some other professionals have other 
health insurance. 
The Social Insurance Institute (IKA) is the largest insurance body in Greece and 
covers more than half the population. It provides health care for 5,550,000 insured persons, 
including family members, and pays pensions to 845,000 pensioners. It provides cover for 
insured persons and pensioners throughout their life. The Institute’s income comes from 
contributions of employees and employers and from government funding. Persons with 
IKA insurance are entitled to benefits in kind – medical, pharmaceutical, hospital and 
dental care, additional health care and preventive medicine, and to cash benefits in the 
form of the maternity grant, the pregnancy and confinement allowance, sickness and 
accident benefits, the death grant and pensions. 
1.4 Sickness insurance 
35)
Insurance by IKA (Social Insurance Institute) is compulsory and covers 
employed persons working in Greece or abroad (for employers whose headquarters are in 
Greece). The insurance also covers persons who are not insured by any other main 
insurance fund and are working under service lease for a specified period as a primary or 
secondary employment, and, finally, persons employed on a non-permanent basis. Those 
persons are insured through their trade union or insurance association. 
Apart from the public hospitals, there are private hospitals, and also private doctors. 




1.5 Doctors and pharmacists 
All medical examinations carried out by doctors in IKA surgeries and medical 
centres by contractual doctors or IKA doctors at home, are free of charge for insured 
people and their family members. General and specific tests in IKA laboratories are also 
free of charge, as is dental treatment. 
A portion of the fee for a visit to a private doctor, and of the cost of medicines in 
case of emergency, is reimbursed in accordance with the rates in force. 
 Dental care is free of charge, but only when provided by dental surgeries of IKA, by 
orthodontic and stomatological centres of IKA or by dentists contracted to IKA in 
their own surgeries 
 In an emergency, persons insured with IKA can go to an IKA Immediate Aid Centre 
 General and specific tests can be carried out by IKA laboratories or by laboratories 
contracted to IKA 
 The cost of prosthetics and major appliances, such as pacemakers, hearing aids, 
wheelchairs, contact lenses, is covered by IKA on receipt of a medical report from 
the attending physician. 
On the other hand, there is big percentage of doctors prefering to work in private 
section because they are working under better conditions with their own schedules and 
their fees are higher. 
1.6 Hospitals and Health Care Arrangements 
Treatment in IKA hospitals, public hospitals and private clinics contracted to IKA, 
and in clinics for chronic conditions and handicapped children is provided free of charge. 
Your IKA doctor, who has to give prior approval, arranges admission to a hospital. 
 IKA hospital care covers all hospitalisation expenses of insured persons and 
pensioners and their family members 
 Insurance is compulsory and starts from the first day of employment. Both employers 
and employees participate in insurance contributions to IKA. Employers are required 
to pay their own contributions (employer's contribution) and the amounts that they 
deduct from their employees' wages or salaries (employee's contribution) to the local 
IKA office at the end of each month. 
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 Each contribution month relates to the working days of the previous month, i.e. the 
contributions of January must be paid at the end of February 
 The amount paid to IKA is a percentage of the gross wage or salary of the employee. 
Higher earnings and more working days equate to higher benefits 
 If the employee is to work at his or her employer’s home (gardeners, domestic 
servants, chefs, etc.), the employer must notify the fact to the local IKA office when 
the employment commences, so that the insurance can begin. 
City hospitals of the national health system,typically offer outpatient care weekdays 
with some departments closing early,handling emergencies outside normal hours on a 
rotating basis.These hospitals will only provide basic services and can be  open as little as 
two hours a day,switching between summer and  winter schedules.On the other hand,there 
are also the private hospitals which provide private medical care more trustworthy and 
convenient with all day schedules.As a result,an increasing number of residents willingly 





Picture 2:Development of Hospitalization Charges(36
 
 
Chapter 2: The role of Pharmacist in Public Health 
2.1 Introduction 
It is fact that the role of a pharmacist is very vital in many aspects. Pharmacists 
have many duties and responsibilities towards the patients and society in general. First of 
all, they distribute prescription drugs to individuals.  
They advise their patients, physicians, and other health practitioners on the 
selection, dosages, interactions, and side effects of medications. Moreover, they monitor 
the health and progress of those patients to ensure that they are using their medications 
safely and effectively.  
Pharmacists in community pharmacies dispense medications, counsel patients on 
the use of prescription and over-the-counter medications, and advise physicians about 
medication therapy. They also advise patients about general health topics, such as diet, 
exercise, and stress management, and provide information on products, such as durable 
medical equipment or home healthcare supplies.   
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Some community pharmacists provide specialized services to help patients with 
conditions such as diabetes, asthma, smoking cessation, or high blood pressure. Some 
others are trained to administer vaccinations. It also needs to be mentioned that some 
pharmacists are involved in research for pharmaceutical companies, developing new drugs 
and testing their effects. 
Others work in marketing or sales, providing clients with expertise on the use, 
effectiveness, and possible side effects of drugs. Additionally, some pharmacists work for 
health insurance companies, developing pharmacy benefit packages and carrying out cost-
benefit analyses on certain drugs.  
2.2 The main duties of pharmacist  
The main duties of the pharmacist include:  
 Laboratory processing,  
 production of new drugs and medical supplies ,  
 quality control and action of drugs ,  
 preparation of drugs which are not received in packaged form   
 Provision of drugs under prescription drugs or drugs that are available to the public on 
free  
 Information of customers about how to obtain and drug and its substances 
 Provides guides to the work of his assistants in the laboratory 
  Information for the status of stored drugs and the supplement of the quantities that are 
necessary for the operation of the pharmacy,  
 Advice on making medicines for the use of various medical devices and general 
medication,  
 Keep records of prescriptions that has performed and the toxic preparations that has 
 Commercial or advisory activity in pharmaceutical companies  





2.3 The role of pharmacist in public health and how it can be developed 
 The role of the pharmacist has acquired a significant importance in latest years, as 
the increased requirements have as a result the creation of greater obligations that 
pharmacist should respond. More specifically, the pharmacist: 
 Must inform and highlight in the society that prevention is what we should seek not the 
treatments as many people believe today. Millions of lives could have been saved if 
this applied in practice. 
 Has an obligation to lert the community and the state against phenomena such as 
counterfeit drugs and doping and to require tighter controls, a more stringent legislative 
framework from governments for the movement of such goods, and of course in 
constant vigilance.  
Still, they must inform all stakeholders and especially to push those responsible to 
obtain a responsible attitude to the problem. (Tsikandilakis, 2009) 
 Pharmacist is the health care professional, who knows more than anyone else the size 
of the problem of drugs and the addiction of drugs, not only due to his scientific 
training but also due to his experience in pharmacy. He is perhaps the only health care 
professional, who knows the so-called "hidden population" of addicts in his region, but 
also the behavior and the action of these. 
It is quite common for the addicts to daily visit our pharmacy to ask for insulin 
syringes and many are those, who try to fake prescriptions to get a sleeping drug. The 
pharmacist, through his experience, should recognize and behave accordingly. It is fact that 
until today there has not been a collective effort to assist these people through the 
pharmaceutical industry. 
However, it is quite difficult, even for someone qualified to talk about detox at the 
moment, a person reaches to the pharmacy to ask syringe, the time that you only have in 
mind is to ensure the dose.  
But in the field of information and guidance at family level, the pharmacist can play 
an important role. The pharmacist must be informed about the problem and provides 
information to the parents and other interested parties. It is time, as pharmacies are 
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advisory stations at various healthy issues, pharmacist can contribute as he can to alleviate 
the problem. (Xanthopoulos, 2005) 
 In border islands, villages and other places where there are no other available health 
services center, the pharmacist plays an important role in the community. The 
pharmacy in the village or the island of barren line is the only oasis of hope and safety 
for the residents of these areas. Pharmacies are required by the state to subsidize and to 
encourage other fellow pharmacists to try their luck in such places. Also the 
pharmacies keep residents in their area, and provide invaluable national service. 
 Involved in voluntary non-governmental organizations (Pharmacists world) or social 
actions (Social Pharmacy), while it is quite helpful their offer in medicines in case of 
war or humanitarian crises. It is necessary to be free from the bureaucratic obligations 
of the state and the pension funds set, as to focus solely on the patient and his 
medication. 
 Required to work with honesty and sincerity reimbursed. On the other side, it is 
important to become tighter controls on pharmacies, to be strict a punishment of the 
offending pharmacists but also a strict compliance with the obligations of the insurance 
funds to pharmacies. Also, it is important a cooperation in keeping drug consumption 
files, cooperation in drawing up the list of drugs that would not be justified at 
redemption. 
 He should also be subsidized from the insurance funds or from another carrier for the 
operation of pharmacies in remote and inaccessible places. The pharmacist must 
support the social security system with all its strength. If he is working as a private 
individual, he must support the public nature of the health system. 
 He should collaborate with the academic institutions. They can also create 
collaborations on issues of proper medication use, side effects and recording training of 
pharmacists, or in other words a pharmacist needs lifelong education. 
 They need to have a better cooperation with pharmaceutical companies so that finally 
they found and other points of contact and cooperation, not only in providing discounts 
or gifts.  
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 Also, it is important to overcoming the distrust that exists between pharmacists and 
companies and to promote scientific cooperation, training, retraining and anything else 
that can help the community. 
 He should work closely with other scientists, such as doctors, nurses, chemists, 
agronomists, estheticians.  
 Finally, he can participate more effectively in actions that have to do with the 
protection of the environment (recycling drugs for example).
32) 
 9)  
2.4 General principles of ethics of pharmacists 
This section lists the articles that constitute the general and specific principles of 
ethics of the pharmaceutical profession. 
Article 1 
The pharmaceutical exercised solely by a University diploma in pharmacy and legal 
authorization to practice the profession of pharmacy.  
Article 2 
The drug is an important factor in the prevention and treatment of disease and the 
pharmacist is the only material specialist in the field of drug trafficking because of his 
scientific education.  
Article 3 
To protect the public health and consumer interests, responsibility and participation 
of pharmacist should cover all stages of the production process as the administration of the 
drug to the public 
Article 4 
Pharmacies should belong exclusively to pharmacists so to avoid interference of 
foreign interests, unrelated to the pharmaceutical profession - function within the 
marketing and retail distribution of pharmaceutical products. This article is of particular 
importance since last year discussed the possibility of ownership of pharmacies by non-




It is an inalienable right of free patient choice of pharmacy owners and pharmacists 
pharmacy operation must avoid any means or manner or method that would limit the 
freedom of choice of the patient's pharmacy of preference. This is absolutely true and the 
various providers of pharmaceutical care to the Greek people.  
Article 6 
Ethics are the principles that govern and guide pharmacists with proprietary owner 
or chief operating pharmacy in their dealings with patients, colleagues and other health 
scientists, the institutions of the state, the collective bodies to which they belong and 
general attitude them to society (FEK, 312 (16/9/92)). 
 
2.5 Liability and dignity of pharmacists 
According to the FEK, 312 (16/9/92), the liability and dignity of pharmacists is 
described in the eight above articles, as following: 
Article 14 
The pharmacist must exercise personally the pharmaceutical and prepares and 
personally delivers medications to patients or their relatives. We personally oversee every 
pharmaceutical work performed by the staff of the pharmacy. 
Article 15 
Each pharmacy must have a conspicuous place on the front, the name of a licensed 
pharmacist, and the signals enforce existing laws. 
Inherited pharmacies will indicate below the name of the deceased pharmacist and 






If ethical breaches his replacement licensed pharmacist, the Disciplinary Board will 
address these offenses should assess and the possible involvement of a licensed pharmacist 
to them and the need to attribute responsibilities and fees. 
Article 17 
The pharmacist must indicate in writing to the pharmacists of the area of any 
change in address of the pharmacy, any interruption in carrying out his duties or 
responsibility of any recruitment partner or dissolution of the company or partnership of 
Co – location. 
Article 18 
Prohibited pharmacists licensees to establish and operate a pharmacy or 
pharmacists responsible for hereditary pharmacies and beneficiaries inheritance pharmacy 
congregation particular individual contracts with insurance funds, as long as the law does 
not provide such discretion, subject always to the provisions of Article 21 of the A. P. 
1384-1398, with terms different from those who have accepted the P.F.S. and the 
pharmaceutical society of which he is a member of the pharmacist. 
Article 19 
The pharmacist and pharmacy operation or the pharmacist responsible for 
hereditary pharmacy must not accept remuneration incompatible with the dignity of the 
office of the pharmacist. 
Article 20 
The pharmacist must give clear instructions of administered drugs to customers of 
the pharmacy and indicate thereon summaries instruction manual and any other label to 




The pharmacist when providing the drugs listed in recipes and other traded 





Chapter 3: Existing Pharmaceutical legislation 
3.1 Directive 432/85/EEC about the education of pharmacists 
“The Directives apply to activities, the access to and pursuit of which are subject to 
the conditions of professional qualifications defined in Council Directive 85/432/EEC and 
which are open to holders of one of the diplomas, certificates or other formal qualifications 
in pharmacy referred to in the Directive. 
Each Member State must recognize the diplomas, certificates and other formal 
qualifications listed in the Directive and awarded by other Member States. They must give 
to such qualifications the same effect in their territory with regard to access to and the 
pursuit of the activities in question as the diplomas, certificates and other formal 
qualifications which they themselves award.  
Examples of qualifications include: 
 Belgium: "diplôme légal de pharmacien"; 
 Ireland: Certificate of Registered Pharmaceutical Chemist; 
 Spain: "titulo de licenciado en farmacia". 
 Furthermore, when access to or the pursuit of the activity in a Member State requires additional 
professional experience, that Member State is obliged to accept as sufficient evidence a 
certificate issued by the competent authorities of the applicant's Member State attesting that he 
has pursued the said activities for an equivalent period. 
Greece is authorized to give effect to the diplomas, certificates and other formal 
qualifications awarded by the other Member States only in cases of pursuit of the activities 
concerned as an employed person.  
The other Member States are required to give effect to diplomas, certificates and 
other formal qualifications awarded in Greece only in cases of pursuit of the activities 
concerned as an employed person. 
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Directive 90/658/EEC introduces a special arrangement for the recognition of 
diplomas, certificates and other evidence of formal qualifications awarded by the former 
German Democratic Republic: German nationals who are pursuing their professional 
activities in that territory on the basis of training which began before unification and does 
not conform to Community rules on training are to be granted recognition under the same 
conditions as other nationals of Member States at the time of the adoption of this Directive, 
i.e. if they produce a certificate showing that they had at least three consecutive years' 
professional practice during the five years prior to the date of issue of the certificate. 
Host Member States must ensure that nationals of Member States who fulfill the 
conditions laid down have the right to use their lawful academic title in the language of the 
Member State from which they come. 
About the procedure for the recognition of pharmacists, according to this directive, 
a host Member State which requires of its nationals proof of good character or good repute 
or a certificate of physical or mental health when they take up the activities specified must 
accept as sufficient evidence, in respect of nationals of other Member States, a certificate 
issued by a competent authority in the Member State from which the foreign national 
comes. 
In particular, Directive 2001/19/EC aims to: 
 Incorporate into Directive 89/48/EEC the concept of "regulated education and 
training", already enshrined in Directive 92/51/EEC. The goal is to require the host 
Member State to take into account the education received by the applicant, including 
education received in a Member State in which the profession in question is not 
regulated. Under this new rule host Member States will not be permitted to require two 
years' professional experience; 
 Ensure that the host Member State, when examining an application for recognition of a 
diploma, takes into consideration the experience acquired by the applicant after 
obtaining the diploma. The host Member State may no longer systematically require 
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the applicant to take compensation steps, such as aptitude tests or an adaptation period, 
but must simplify and if possible eliminate these measures; 
 Ensure legal certainty with regard to the recognition of diplomas obtained by 
Community nationals in third countries; the envisaged system gives each Member State 
the right to recognize or reject these diplomas except when a first host Member State 
has already recognized the applicant's professional experience. In this case a second 
host Member State may not directly reject the application for recognition but must 
justify its rejection; 
 Extend the automatic recognition procedure, already applicable to general practitioners, 
to other physicians and to nurses responsible for general care, dental practitioners, 
veterinary surgeons, midwives and pharmacists. The main simplification lies in the 
updating of the lists of diplomas recognized at European level, since the Commission 
will from now on be able to publish lists of diplomas notified by the Member States on 
a regular basis (annexed to this document)”. (Directive 85/433/EEC) 
3.2 Directive 2005/36 EC for the recognition of professional qualifications 
In contrast the previous directive, this directive makes a distinction between 
“freedom to provide services” and “freedom of establishment” on the basis of criteria 
identified by the Court of Justice: duration, frequency, regularity and continuity of the 
provision of services. This directive replaces both directives above, which referred only to 
pharmacists. In addition to this, the new Directive refers to more regulated professions. 
According to this directive, “The general system applies to professions not covered 
by specific rules of recognition and to certain situations where the professional does not 
meet the conditions set out in other recognition schemes. This system is based on the 
principle of mutual recognition, without prejudice to the application of compensatory 
measures if there are substantial differences between the training that acquired by the 
person concerned and the training required in the host Member State. The compensatory 
measure may take the form of an adaptation period or an aptitude test. The choice is left to 
the person concerned, unless specific derogations exist. 
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When access to or pursuit of a profession is regulated in the host Member State, i.e. 
it is subject to possession of specific professional qualifications, the competent authority in 
said Member State is to allow access to the profession in question and pursuit thereof under 
the same conditions as for its nationals. However, the applicant must hold a training 
qualification obtained in another Member State that attests to a level of training at least 
equivalent to the level immediately below that required in the host Member State. 
On the other hand, when access to a profession is not subject to possession of 
specific professional qualifications in the applicant’s Member State, access to that 
profession in a host Member State where it is regulated requires proof of two years' full-
time professional experience over the preceding ten years in addition to the qualification”. 
In practice, “the directive distinguishes five levels of professional qualifications are 
the followings: 
 attestation of competence issued by a competent authority in the home Member State, 
attesting either that the holder has acquired general knowledge corresponding to 
primary or secondary education, or has undergone training not forming part of a 
certificate or diploma, or has taken a specific examination without previous training or 
has three years' professional experience; 
 certificate corresponding to training at secondary level of a technical or professional 
nature or general in character, supplemented by a professional course; 
 diploma certifying successful completion of training at post-secondary level of a 
duration of at least one year or professional training that is comparable in terms of 
responsibilities and functions; 
 diploma certifying successful completion of training at higher or university level of a 
duration of at least three years and not exceeding four years; 
 Diploma certifying successful completion of training at higher or university level of a 
duration of at least four years”. 
On the other side, “the host Member State can make recognition of qualifications 
subject to the applicant completing a compensation measure (aptitude test or adaptation 
period of a maximum of three years) in the following three cases: 
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 the training was at least one year shorter than that required by the host Member State; 
 the training covered substantially different matters from those covered by the evidence 
of formal training required in the host Member State; 
 The profession as defined in the host Member State comprises one or more regulated 
professional activities that do not exist in the corresponding profession in the 
applicant’s home Member State and requires specific training that covers substantially 
different matters from those covered by the applicant's training. 
The directive allows representative professional associations at both national and 
European level to propose common platforms to compensate for the substantial differences 
identified between Member States' training requirements. The platform is a way of 
ensuring that additional measures are not imposed on those concerned, while guaranteeing 
an appropriate qualification level. The platform is a kind of predefined compensatory 
measure”. (Directive 2005/36 EC)  
3.3 Pharmaceutical legislation in Greece 
According to the Greek law, the profession is only practiced by pharmacists and by 
this we mean those people that possess the degree of the pharmacist and the license to 
practice their profession. Pharmacies can only belong to pharmacists and it is forbidden to 
anyone who does not have a degree in pharmacy to own such a store. This aims to the 
maintenance of the public health. 
There are documents that describe the deontology that pharmacists should have 
towards their clients, their colleagues, the other medical scientists and their behaviour 
towards society in general. 
According to article 2 of the law 1963/1991 (ΦΕΚ 138 Α΄): 
 
For the protection of public health and the rational distribution of drugs to the 
territory the following limits have been set for municipalities and municipal or communal 
apartments, like they are referred to the article 1 of the law 2539/1997 (ΦΕΚ 244 Α΄): in 
the municipalities and municipal or communal apartments with population up to 1500 (one 
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thousand five hundred) residents only one pharmaceutical license is allowed to be 
provided.  
However, in the municipalities and municipal or communal apartments with 
population over 1500 residents, the ratio of pharmaceutical licenses to residents is 1:1500 
and this means that only one pharmacy is allowed to be built for every 1500residents. The 
population is calculated according to the result of the last inventory. 
As far as the distances are concerned among adjacent pharmacies: 
 One hundred meters at least in the municipalities and municipal or communal 
apartments with population up to 5.000 residents. 
 One hundred and eighty meters at least in the municipalities and municipal or 
communal apartments with population from 5.000 to 100.000 residents. 
 Two hundred meters at least in the municipalities and municipal or communal 
apartments with population from 100.000 to 200.000 residents. 
 Two hundred and fifty meters at least in the municipalities and municipal or communal 
apartments with population over 200.000 residents. 
 
In some cases, the pharmacies can be transferred to a different location but inside 
the geographical boundaries of the municipalities and municipal or communal apartments. 
This can only happen under the following circumstances:  
 
After eight years of function, the pharmacy can be transferred at least forty meters 
far from the adjacent pharmacies. After ten years of function, the pharmacy can be 
transferred at least twenty meters far from the adjacent pharmacies. 
 
The license for the erection of a new pharmacy is given, after the meeting and the 
consultation of the local chamber, by decision of the responsible prefect within the 




It is worth noting that under the memorandum there are a number of amendments to 
existing legislation, which are voted from Greek parliament in March 2014. These include: 
 
 A pharmacist may have more than one license pharmacy. 
 It can also hold any share capital wishes, an operator of a pharmacy. 
 Pharmacies can be housed in any store. 
 The land use criteria for new pharmacy are abolished 
 Everyone may create pharmacy 100 meters from the hospital gate 
 Repealed earlier arrangement by which the wholesalers were required to have a 
specific buffer. 
 The profit rates for pharmacists are abolished for non- mandatory prescription drugs 
(MYSYFA). 
 By the end of 2016, there are increasing rates of circulating MYSYFA. 
 The MYSYFA that placed on, will be sold at the same or a lower price as the 
corresponding already available. 
 There is a free possibility for free discounts on MYSYFA. 
 The stringent provisions are abolished in relation to the period of patent protection of 
medicines. 
 Pharmacists can be freely extended hours. (FEK 138 1963/1991) 
Chapter 4: Professional license  
4.1 Conditions for professional license  
The first condition under which any student with a degree in pharmacy can obtain 
his professional license is to sit exams in order to prove his knowledge concerning 
pharmaceutical matters.  
There are two examination centers in the country, one in Athens and one in 
Thessaloniki. The lessons that students should be aware of are pharmacology, toxicology, 
pharmaceutical technology, legislation concerning their profession and they also should 
know everything about prescriptions. The dates that students can participate in the exams 
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are always announced by the Ministry for Health and Social Solidarity and exams are 
usually carried out five times within a year. 
Another condition in order to obtain their license is to fulfill a whole year practice 
in a private drugstore which is open to the public and in a hospital’s drugstore. 
After passing successfully the exams and having completed their year-practice, 
what remains to be done is to provide some supporting documents to the Public Health 
Directorate.  
These documents contain an application form, proof of their degree or equivalent 
degree for those who have studied outside, proof of their work in drugstores during their 
practice, proof of passing the exams successfully, certified copy of their identity card, 
proof of clean criminal record, photocopies and an amount of money. Moreover, for 
foreigners is required permanent resident status as well as license of reciprocity from the 
Ministry of Foreign Affairs. (FEK 138 1963/1991) 
Greek students also have the chance to sit similar exams in Cyprus in order to 
obtain their professional license. However, in that case the students are examined on the 
Cypriot legislation concerning pharmacies. After passing those exams successfully, they 
also have to provide some documents in order to get the license. (FEK 138 1963/1991) 
 
4.2 Documents for Greek Universities graduates 
These documents contain an application form, proof of having passed the exams 
successfully, a health certificate from a pathologist of the public sector, a mental health 
certificate from a public mental health center, certified copy of their identity card, proof of 
clean criminal record, photocopies and an amount of money. 
Summarizing, according to the Greek law 3457/2006 the main conditions that 
someone should have in an attempt to gain a professional license are the followings: 
1) Bachelor.  
2) Internship twelve months (six months in a pharmacy open to the public three months in 




3) Successful exam 
Required documents: 
1) Application (available from the department) 
2) Duplicate Greek university degree in Pharmacy or equivalent degree from DOATAP 
for graduates from school foreign country . 
3) Certificates internships 
4) Certification exam success 
5) Affidavit of N.1599/86 ( GG 1637/V/7-11-2006 ) that: " I have not been convicted of 
any offense or an act relating to the exercise of my professional status " otherwise "I 
have ordered for the following offenses ........ " instead of criminal record) 
6) Photocopy of a validated identify 
7) Payment of a prevailing government fund 
8)  Two photos  
9) For foreign people, it is required the residence and reciprocity certificate by the 
Ministry of Foreign Affairs. (Law 3457/2006) 
4.3 Documents for graduates of Universities Abroad - non EU Member 
States 
The main documents for the non EU member States, who have a certificate from a 
University abroad, are: 
 Application (Application for a license to practice ) 
 A copy of the foreign diploma and official translations thereof (Certificate of DOATAP 
on the rate and correlation with the degrees of pharmaceutical faculties of Greek 
universities ) . 
 Certificate of biennial exercise in Pharmacy resident (during the summer holidays or 
after completion of studies) or foreign certificate showing analytically the exercise 
time, will bring his signature stamp and signature Pharmacist , certified by the 
president of the relevant Pharmaceutical Association , the local prefecture and the 
Greek Consul in official translation.  
 A certificate of Greek nationality. 
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  Fee stamp of 30 € and a government fee of 8 €. 
 A copy of criminal record (mandatory automatic search for criminal records or court of 
general use , DIADP/A/22863/06 FEK/V/1551/23-10-06 ) 
 Photocopy of ID card that should be validated. 
 Two recent photos 
 A prosecution certificate or statutory declaration (not prosecuted as either a fugitive 
from justice). 
 For expatriates, work permit (from the Ministry of Labour) and subsistence (of the 
Foreign Division of the Ministry of Public Order) For foreigners also reciprocity 
certificate by the Ministry of Foreign Affairs, except those from Member States of the 
EU. (Law 3457/2006) 
4.4 Documents for graduates of Universities Abroad - EU Member States 
The main documents for the EU member States, who have a certificate from a 
University abroad, are: 
 Application (Application for a license to practice) 
 A copy of the diploma with an official translation. 
 Diploma, certificate or other evidence of drug than those referred to in paragraph 2 
of Article 5 of Presidential Decree 213 / 03 for the exercise of the pharmaceutical 
profession in the country of origin or provenance (with official translation). 
 Certificate attesting that the applicant meet the minimum training requirements or 
other conditions for the award of a diploma, certificate or other evidence of drug for 
the exercise of the pharmaceutical profession (Articles 3, 4 and 5 of Presidential 
Decree No. 213 sgd "Adaptation of Greek legislation to the provisions of Directives 
85/432/EEC , 85/433/EEC , 85/584/EEC, 90/658/EEC and Directive 2001/19/EC , 
relating to the profession of pharmacy." 
 Citizenship certificate. 
 Certificate of good character and repute of the competent authority of the Member 
State of origin or to enter the pharmaceutical profession and start the exercise 
thereof or an extract or failing that, an equivalent document issued by the 
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competent authority of the Member State of origin or provenance (Not applicable if 
submitted within three months of their issue . 
 Copy of criminal record (mandatory automatic search for criminal records or court 
of general use , DIADP/A/22863/06 FEK/V/1551/23-10-06 ) 
Prosecution Certificate or Statutory Declaration ( not prosecuted as either a fugitive 
from justice ) . 
  Photocopy of an ID card that is  validated 
 A permission about residence  
 Two recent photos 
 A certificate military status (males). 
 Fee stamp of 30 € and a government fee of 8 €. (Law 3457/2006) 
 
CHAPTER 5:Permit the establishment of pharmacies and authorization of 
pharmacies 
5.1 Permission of pharmacies 
In Greece the accurately number of pharmacies is 11.482(calculated on 2013).The 
procedure to get the license or the authorization to establish a pharmacy differs from the 
one mentioned above. In this case, the applicant should meet the criteria below which are 
certified by documents submitted by relevant authorities. 
 The applicant must be Greek citizen or must have citizenship among the nations of the 
European Union.  
 He also must have a degree in pharmacy and a professional license obtained in Greece 
or in another country of the European Union which have been proved to be equivalent. 
 He must have carried out his military duties or must legally be exempted from them. 
 He must not have been condemned to an offense or a crime or any violation and must 
have clean criminal record. 
A license to establish a pharmacy is not granted to pharmacists that: 
 
 receive a pension for health reasons from social security institutions 
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 have been punished for offences concerning their profession 
 have completed the seventieth year of their age 
The order of preference concerning the obtaining of the license to establish a 
pharmacy is conducted as followings: 
The license is given firstly to the pharmacist that has submitted an application to 
the relevant authorities earlier than others. That means that the date that the pharmacist 
declares the need to establish a pharmacy plays an essential role. (Law 3457/2006) 
Among those who have submitted an application to the relevant authorities during 
the same day, the one who is preferred is the pharmacist  
 who does not have license to establish a pharmacy in any other municipality or 
communal apartment 
 who has obtained his professional license earlier and has never before obtained license 
to establish a pharmacy 
 who has obtained his diploma earlier and in the case there are pharmacists that have 
obtained their degree at the same time, the one who has achieved higher grades is 
preferred  
 Who has many children (at least three) or is coming from a family that has many 
members. (Law 3457/2006) 
It is also worth noting that there are population criteria for the choice to permit the 
establishment of a pharmacy in Greece. More specifically, there is a ratio of one pharmacy 
per 1,000 inhabitants. Establishing a second pharmacy must complete the second thousand, 
establishing third pharmacy must complete the third thousand etc. 
Also, in local or municipal communities, with a population of 1000 inhabitants may 







5.2 Documents for the authorization of establishment a pharmacy 
The main documents that someone should provide in an attempt to take a grant for 
an establishment of a pharmacy are: 
 Application (served by the bailiff) 
 Copy of diploma in pharmacy school 
 A copy of the license to practice as a pharmacist in Greece 
 Certificate municipality or community that has Greek nationality 
 An  affidavit with the following: " I have not been irrevocably sentenced for theft , 
embezzlement , fraud , extortion , forgery , crimes against morality , slander for acts 
connected with the exercise of the profession , counterfeiting, forgery , breach of 
Article 5 the N1729/1987 , FEK144 / D and recurrent Article 11 of the same law or 
have not been irrevocably sentenced for a felony or recurrent misdemeanor for which 
imposed deprivation of political rights or may not have been referred to the irrevocable 
decree for any of the above offenses . Also I have not punished for violations of drug 
laws to permanent revocation of license establishing the pharmacy or drugstore "or 
otherwise "... I have been convicted of the following offenses ... ". 
 Certificate of Public Prosecutions (not prosecuted as either a fugitive from justice) 
 Certificate military status type A 
 An affidavit of Article 8 of N 1599/86 that it revoked the license pharmacy , drugstore 
or laboratory for violations of drug laws , does not get a full state pension , the TSAI or 
any other institution or social security does not receive pension for health reasons and 
has not reached full retirement conditions , does not hold a public or private place and 
not another direct - pharmaceutical wholesaler pharmacy or laboratory medicine and 
cosmetics 
 An affidavit of Article 8 of N 1599/86 that I have filed another application for Regional 
Unity license Foundation Pharmacy. 
 A promissory stock 6, 00 € fund depository and loan (secured for authorization to 
establish a pharmacy). 
 Photocopy of ID card validated  
 A paper folder with elastic. (Law 3457/2006) 
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5.3 Documents for the authorization for a dispensation of established a 
Pharmacy 
 
The main documents that someone should provide in an attempt to take a grant for 
an establishment of a pharmacy in a dispensation are: 
 Application (served by the bailiff) 
 Certified copy of diploma in pharmacy school 
 A certified copy of a license to practice as a pharmacist in Greece 
 Certificate municipality or community that has Greek nationality certificate of Public 
Prosecutions 
 An affidavit with the following: "I have not been irrevocably sentenced for theft , 
embezzlement, fraud, extortion, forgery, crimes against morality, slander for acts 
connected with the exercise of the profession, counterfeiting, forgery , breach of Article 
5 the N1729/1987 , FEK144 / D and recurrent Article 11 of the same law or have not 
been irrevocably sentenced for a felony or recurrent misdemeanor for which imposed 
deprivation of political rights or may not have been referred to the irrevocable decree 
for any of the above offenses . Also I have not punished for violations of drug laws to 
permanent revocation of license establishing the pharmacy or drugstore "or otherwise 
... I have been convicted of the following offenses ... ". 
 A certificate of military status A (mandatory automatic search from our Service) 
 Affidavit of Article 8 of N 1599/86 that it revoked the license pharmacy , drugstore or 
laboratory for violations of drug laws , does not get a full state pension, then, social 
security does not receive pension for health reasons and has not reached full retirement 
conditions , does not hold a public or private place and not another direct - 
pharmaceutical wholesaler pharmacy or laboratory medicine and cosmetics (if it holds 
another position will withdraw it with the approval of the operation of the pharmacy) 
 An affidavit of Article 8 of N 1599/86 that I have not filed in another county request 
for permission Pharmacy Foundation.  
 A Bill deposit from the Deposits and Loans Fund. 
A photocopy of the identities cards both of two pharmacists.  
36 
 
5.4 Co – licensed pharmacies 
Moreover, the state gives the possibility for a co-location of pharmacies, which means 
that with prefect's decision after consulting with the pharmaceutical association, it may allow the 
co-location of the same store more than one establishment in pharmacies, as long as you do not 
obstruct the spatial serve the public and not declared function in a specific store or pharmacy 
nascent transfer pharmacy already working in another position, less than the planned. 
Similarly, it may allow the co-location of pharmacies in establishing a functioning 
pharmacies and pharmacies that operated together. 
Also, the co-location is allowed in the same store pharmaceutical warehouses under 
establishment, operation and in establishing a functioning of wholesalers. 
In practice, licensed co - located pharmacists and pharmaceutical warehouses are 
jointly responsible for any breach of the law, the personal direction and the normal 
operation of pharmacies and pharmaceutical warehouses and are required to indicate their 
names on display and these inscriptions 
In addition, the co-location between pharmacies those operate between and 
operated with pharmacies to be established, not authorized, and permitted regardless of the 
distance they are from another pharmacy or co-location 
Regarding the operation of co-located pharmacies, those are considered as 
operating separately and are required to be a living room and a special night. 
So, in the event of retirement, resignation for health reasons or death of a 
pharmacist in the store was approved or approved co-location, in accordance with the 
preceding paragraphs do not apply, the winding of co – located for the remaining there in 
pharmacists on area and distance provisions. 
Co-location pharmacies work required to form of a general partnership, which 
recommended under an authenticated paper, which designated to joint directors of all 
participants in the co-location of pharmacists, in which all pharmacists participate with the 




5.5 Division of pharmacies in Greece 
Greek hospitals wishing to have in-house pharmacies must receive authorization 
from the local health department and submit to an examination from a regional inspector. 
Once established, the pharmacy is granted an annual budget that pays for drugs, medical 
devices, and other pharmaceutical products, but not for salaries. The number of 
pharmacists per bed in Greek hospitals is quite low, typically only one or two in a medium 
hospital of 200 – 400 beds. This serious shortage of personnel (and software too)means 
that, even though prescriptions should ideally be analyzed by the hospital pharmacist and 
dispensed in unit doses, drugs are still distributed in bulk in many hospitals, based on lists 
of orders from the wards. Greek hospital pharmacies purchase drugs for hospitalized 
patients, outpatients under specialpharmacotherapy such as cancer treatment, and indigent 
patients covered by Social Security. Indigent patients can only receive their drugs free of 
charge directly from hospital pharmacies. Drug pricing in hospital pharmacies is different 
from that in community pharmacies, resulting from consultations made by the Ministries of 
Health and Commerce with the pharmaceutical industries 
 
Chapter 6: Operation pharmacy 
 
6.1 Procedure after the authorization for the establishment of a 
pharmacy 
Upon notification by the District of decisions regarding the authorization for the 
establishment of a pharmacy in a certain Municipality in the claimant pharmacist, he 
should within six months to draw up the pharmacy in a specific store.  
If this period of six months for establishing pharmacy passed without the settlement 
of a pharmacy, then the license becomes null and void and the forfeit paid to the public. 
6.2 Documents for the operation pharmacy 
The main documents for the operation pharmacy are the followings: 
 Applicant's application (Application for a license to operate a pharmacy ) 
 Royalty foundation (decision notified) . 
 Copy of lease agreement by the applicant pharmacist on the premises where you 
operate a pharmacy or a recent certificate of ownership of the land register (stamped by 
the tax office) 
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 Excerpt of a street plan of the area at a scale of 1:200, which will occur pharmacies that 
are near the pharmacy concerned up to a distance of one hundred (100) meters for 
district with a population of 5,000 inhabitants located up to one hundred eighty (180) 
measures district with a population of 5,000 to 100,000 inhabitants. 
 Top view of pharmacy in 1:50 scale which will show the net dimensions  
 A Certificate of the Urban Service that ensures the store is not arbitrary and does not 
include arbitrary structures or additions. 
 Certificate of a fire brigade. 
 Affidavit of engineering testimony in Snippet Street plan pharmacies and drew the 
floor plan of pharmacy stating that: "the data in a street map and a plan view of 
pharmacy is accurate." 
It is also noting that it is possible to ensure pharmacy location (before issuing 
authorization and authority of the requirements for the position and building) of its filing 
accompanied by concession or lease or purchase agreement for building. 
6.3 Organization and formation of a pharmacy 
The presidential decree 312 (16-9-92) defines regarding the organization and 
formation of a pharmacy the followings: 
Article 1, paragraph 1: 
 In pharmacy are performed all kinds of recipes that quoted by doctors, dentists, 
midwives and also the veterinarians recipes and  
 Retailed medicines pharmaceutical products and pharmaceutical substances, except 
those with decision EOF excluded the jurisdiction of pharmacies and species as 
authorized by other provisions of law or decisions.  
 Also sold in pharmacies free articles general medicine, cosmetics , dietary products, 
milk and infant foods, toiletries infants, pregnant and postpartum, cosmetic, orthopedic 
equipment and machinery, medical instrument , machines and devices. 
Article 1, paragraph 2: 
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Pharmacies can sell and veterinary drugs, but in this case must have for storage and 
sale of these special addition, which must be prominently displayed in capital letters, the 
words "VETERINARY DRUGS". 
Article 1, paragraph 3: 
The sale in pharmacies foreign objects that not covered by the above paragraphs 1 
and 2 shall be prohibited. 
Article 2, paragraph 1: 
The frontage of the store pharmacies placed mandatory within illuminated panels, 
cross green color, the center of which there may be the display of complex medicinal pot 
and snake. 
Article 2, paragraph 2: 
Pharmacists at the time of labor required to wear a white blouse and the upper left 
side of this bear badge (badge) with their names and functions.  
Also, the white coats are required to carry and licensed pharmacy technicians, with 
their names and functions. (FEK, 312 (16/9/92)) 
Moreover, each pharmacy, according to the law, shall be equipped with drugs that:  
a) specified by the National Organization for Medicines drugs, chemicals, and draggers of Greek 
Pharmacy industry. 
b) Sufficient quantities of proprietary formulations and antibiotics , hormonal , hemostatic 
, cardiotonic , analgesic , therapeutic sera and other current medications to cover the needs of the 
public in relation to the population density of the area , the frequency of a day and nights and this 
general motion operation prescriptions. 
c) Net oxygen canisters, ready for use, along with the necessary parts for use by the 
patient. 
Except drugs, each pharmacy should have a quantity of equipment and utensils and more 
specifically:  
At least two scales, with the necessary weights in the decimal system. A susceptible for 
the weighing of small quantities, with vulnerability 0,005 (5 mm) of a gram and a lower for the 
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weighing of large amounts up to 20 grams.  Also, a scale for weighing the liquids and solids, in 
quantities of kilos. 
b) A porcelain mortar, tongs, spatula, pans, funnels, volumetric tubes, test tubes, filters 
and generally anything, that it can fulfill its intended purpose seamlessly. 
               c) Electric refrigerator. 
d) Safe, permanent and sufficient weight or built an iron box, which will be insured in both 
cases, with security keys or combination of letters or numbers, for storage of drugs, which is 
solely responsible for a licensed pharmacist. 
Also, it should be noting that is prohibited the existence and operation of 
pharmacies within the chemical or microbiological laboratories, the optical parts, unless 
specifically authorized to do so. (FEK, 312 (16/9/92) 
6.4 Pharmacy in operation 
In practice, the address of the pharmacy in person belongs to the owner of a licensed 
pharmacist. Also, as it obvious, violators shall be punished with fine or with immediate 
closure of the pharmacy 
Regarding the absence of the pharmacist may from the pharmacy, the Greek law defines 
that: 
A Pharmacist can absence two months every year continuously or intermittently. The 
permission for these absences is granted from the concerned Medical Officer at the request of the 
pharmacist without any specific reasons. 
If there is no other scientist pharmacist in pharmacy to replace him, then pharmacy 
technicians with supervision of another pharmacist, who has a pharmacy in the same municipality 
or village or a doctor if the Municipality or Community pharmacies are less than three, replace 
him.  
The scientist pharmacist or pharmacy technicians and supervising pharmacist or doctor is 
partly responsible for the normal operation of the pharmacy. 
Also, a pharmacist can absence more than two months, only if he is replaced by another 
pharmacist, who does not manage another pharmacy or pharmaceutical wholesaler and not 
incompatible under Law 1932.  
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The reasons for the authorization of two months is health reasons, trip wider education or 
exceptional reasons that will judge the Administration are adequate. 
 
 
6.5 Royalty temporary closure 
A pharmacist can temporary close its pharmacy, according to the above situations: 
a) Three days (the time) without the permission of the competent authority, however 
requires notification to the competent authority (Department of Health, or address of 
the local prefecture)  
b) One month time without specific reasons after obtaining the assent of the medicinal 
club.  
c) six months for the following reasons:  
 transportation or renovation,  
 for health reasons  
 for economic  reasons 
 For other serious reasons at the discretion of the Competent  
Authority, if he cannot find a replacement. 
In practice, the time of year is considered as temporary closure operation and taken into 
account; regard the distances and the retirement of pharmacist 
Finally, the closure of the pharmacy arbitrarily considered infringement harming public 
health, punishable by a fine or revocation of the license if the pharmacy is closed over three 
months (six months in the case of inheritance pharmacy) without permission of the Competent 
Authority. 
CHAPTER 7:Historical Development of the pharmacist’ association 
7.1 Aim and Priorities 
The Panhellenic Pharmaceutical association is a body corporate under public law 
Ν.3601/1928. It was founded in 1928 under the title of Greek Pharmaceutical Association. 
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Members of SFEE are 60 Pharmaceutical enterprises operating in Greece which cover all 
innovative medicinal products as well as 90% of the pharmaceutical market. 
The Association was created in order to protect and promote the interests of its members 
and to secure the implement of the law. It represents an organism which informs its members and 
furthermore safeguards its significant role to the public health. 
More specifically, the mission of the Hellenic Association of Pharmaceutical Companies 
(SFEE) is to create favorable policy conditions, which will enable the research-based 
pharmaceutical industry to participate and to benefit from the international scientific progress, 
consolidate its competitiveness and contribute to the greater possible development of innovative 
medicinal products to the benefit of the patients' healthcare. 
In addition, a basic aim of SFEE is the creation of policy conditions, adapted to the 
European pharmaceutical policy that consolidates competitiveness and allows for a greater 
possible development of medicinal products in an attempt to the benefit of patients' healthcare. 
One of the significant roles of SFEE is to develop a climate of co-operation with all the 
parties that involved, such as Health Authorities, Public service, Physicians and pharmacists' to 
enable the research-based pharmaceutical industry to meet the present and future expectations 
of Greek citizens.  
Moreover, SFEE is “committed to promote legislative, provisions, economic and political 
conditions and implement existing legislation, which favor the development of innovative 
research. This kind of research leads to new therapies which improve the quality of life and save 
the lives of millions of patients”.  
It is worth noting that the necessary investment for this innovative research will assist the 
Pharmaceutical Industry to contribute to a greater extent to the economic growth, employment 
and industrial competitiveness. 
However, pharmaceutical companies are confronted with a plethora of strict measures 
which are: 
a) “The determination of prices based on the average of the three lowest prices in Europe, 
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b) The establishment of a reimbursement list which will probably result in further 
reduction of the prices of medicinal products in order to include them in this list, 
c) The parallel requirement of compulsory discounts on already low prices, 
d) The additional requirement of a rebate to be paid to social security funds, 
e) The compulsory payment of all costs for the distribution of medicinal products 
throughout the country by pharmaceutical companies, 




About the priorities of SFEE, according to its statute, the main priorities are: 
 “Establishment of SFEE as trustworthy interlocutor and consultant of the political 
leadership so that political decisions are taken after dialogue with representatives of the 
interested parties (physicians, pharmacists, industry, patients) to the benefit of patients' 
care.  
 Creation of favorable climate for research and development of new medicinal products 
by utilizing the scientific potential of the country.  
 Establishment of a legislative framework which will ensure the quality, efficacy and 
safety of new medicinal products.  
 Establishment of conditions for healthy competition so that the policy pursued and 
legislative provisions enhance investments in the research and development of 
innovative medicinal products.  
 Support of investments through legislative provisions which will favor expansion in the 
international market and effective protection of intellectual property.”
16) 
 
Supreme body of the association is the General Assembly and its members are 
gathered occasionally in March and November of every year. Members of the association 
become all the pharmacists that possess a pharmacy legally and they have to conform to 
the internal regulations. 
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The association has organized the function of a Solidarity Fund in order to deal 
with its members’ urgent needs, like severe injury that leads to permanent or contemporary 
disability or destruction of the pharmacy from natural reasons that is out of the 
pharmacist’s control. 
It also provides information to the pharmacists regularly for many scientific topics 
and other news concerning their work. Moreover, it participates in the controls done by the 
officials who are authorized by the Prefecture. It is also considered to be the ‘’voice’’ of all 
the pharmacists and this makes the association powerful. 
Regarding the source of funding of SFEE, these are allocated to regular and 
extraordinary. 
In practice, the regular financial resources are stem from the ordinary members’ 
registration fees, their yearly membership fees and the income from the Association’s 
assets. 
On the other side, extraordinary financial resources are mainly donations, 
inheritances, and all other income legally obtained, as well as extraordinary fees decided 
by the General Assembly and the penalties imposed to the members by the First Degree 
Committee. 
Finally, we can refer that the Association’s registration fee and the yearly 
membership fee paid by ordinary members every calendar year are determined by decision 
of the General Assembly. 
7.2 Structure 
The administration bodies of SFEE are the General Assembly of the Members, the 
Board of Directors, the Director General, and the Disciplinary Board. 
As we said above, Supreme body of the association is the General Assembly and its 
members are gathered occasionally in meetings together with Board of Directors in March 
and November of every year.  
Members of the association become all the pharmacists that possess a pharmacy 
legally and they have to conform to the internal regulations. 
45 
 
During the first meeting, the General Assembly meets in quorum, if at least ½ of 
the ordinary members are present.  Otherwise, the meeting is re-scheduled for the same day 
of the following week, during which ¼ of the members must be present. 
On the other side, the Board of Directors consists of 15 members, elected by the 
General Assembly, the Chairman, six Vice-Chairmen, a Secretary, a Treasurer and six 
Consultants.   
The Board of Directors is elected for a 3-year term and meets on a regular basis 
once a month and it may hold extraordinary meetings whenever 2 ordinary members 
submit such a written request to the Chairman. 
Also, the decisions of Board of Directors are taken by absolute majority of the 
members present, while in case of parity the vote of Chairman prevails. 
More specifically, the Chairman, (or his legal substitute appointed by the Chairman 
during the first meeting of the Board of Directors) presides over the Board meetings, 
represents the Association before all natural persons or legal entities and before any Legal, 
Administrative, Municipal Authority and any other authority whatsoever. 
The General Director supervises the Association services, all communications 
between the Association and the Administrative Authorities, the Ministries, the Political 
Parties, the Mass Media, the Association Members.  The Director General supervises the 
Association’s participation to the collective bodies. 
The Disciplinary Board consists of three members, which elected by the General 
Assembly, and its decisions are taken by simple majority. The Disciplinary Board proposes 
to the General Assembly the deletion of an ordinary member from the Association records, 
if case the ordinary member refuses to conform to the sanctions that may have been 
imposed by SFEE’s Code of Practice Second Degree Committee. 
The Disciplinary Board also reviews all issues that may lead to an ex officio 
deletion of a member from the Association’s records or following an application by an 
ordinary member. 
Finally, two auditors, representing ordinary members, elected by the General 
Assembly, supervise and audit the management of the Association’s financial resources.  
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In practice, the auditors submit to the Regular General Assembly an annual written report, 
on the management of the Association’s financial resources.
15)
  
7.3 Other Pharmaceutical Associations 
The Pharmaceutical Association of Athens (FSA) and Pharmaceutical Association 
of Thessaloniki (FSTH) were established in accordance with the provisions of Law No. 
3601/1928 on the establishment of Pharmaceutical Associations.
13)
  
Both of them work with public entities form and their operation is governed by the 
applicable provisions for drug associations. They are governed by a nine Board elected 
every three years by the General Assembly. 
Members of FSA must be all pharmacists who operate legally their own pharmacy 
in Attica region. Respectively members of FSTH must be also pharmacists who operate 
their own pharmacy in Thessaloniki region. 
From its foundation the FSA: 
 Has signed collective agreements with 42 Social Security Funds. The association 
receives the prescriptions of every pharmacy member and pays them off, covering that 
way the interests of its members. 
 Has a dynamic intervene in cases of problems with members of the Funds , which enter 
into individual contracts with them. 
 Has organized the function of a Solidarity Fund in order to deal with its members’ 
urgent needs, like severe injury that leads to permanent or contemporary disability or 
destruction of the pharmacy from natural reasons that is out of the pharmacist’s control. 
 Provides to its members the fullest information about scientific and sector issues on a 
monthly basis. 
 Participates by representatives on the controls that carried out by the authorized bodies 
in the prefecture during the inspection of pharmacies that are established or are going 
to be authorized. 
 In general is the voice of 40 % of Greek pharmacies, which gives special power and 
prestige as a association. 
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Finally, an ambition and priority of the Board of Directors of the F.S.A. is to 
modernize the profession and providing unwavering support to the pharmacist of Attica, in 
any professional problems that they are face. (http://www.fsa.gr) 
On the other side, FSTH’ aim is the concentration and distribution of prescription 
insurance funds and organizations performing in pharmacies belonging to the power of the 
Pharmaceutical Association in Thessaloniki 
Also, FSTH has established the non-profit organization called "Distributing Account 
membership Pharmaceutical Association Thessaloniki" (DI.LO.F.). The DILOF aims 
primarily to "the concentration and distribution of prescription from insurance funds and 
organizations, which are performing in pharmacies belonging to the power of the 
Pharmaceutical Association of Thessaloniki, the collection of payments through the FSTH 
on behalf of pharmacists and distribution to those of the corresponding amounts", as 
described in its statutes.14)  
CHAPTER 8:National organization for medicines 
8.1 National Drug Organization (EOF) 
The National Drug Organization (EOF) is the main regulatory authority functioning 
under the auspices of the Ministry of Health and Social Solidarity. In 2004, total 
pharmaceutical expenditure in Greece reached the level of 2.9 billion euro, of which 
77.9% were public expenditure and the remaining 22.1% private.  
According to Organization for Economic Cooperation and Development (OECD) 
data, the total per-capita expenditure on pharmaceutical care in Greece was among the 
lowest in Europe. In 1998, Greece introduced a reimbursement list, and the lowest 
reference pricing system among the 15 European Union member states with the purpose 
of controlling the growth of pharmaceutical expenditure.  
The measures proved to be ineffective since pharmaceutical expenditure 
continued to increase at similar rates to those before the introduction of price control 
mechanisms. New pharmaceutical legislation, no. 3457, was enacted on May 8th 2006, 
aiming at greater access to medicines, improvements to citizens' quality of life, effective 
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and efficient utilization of health resources, transparency in public management, 
protecting public health, and maintaining long-term financial viability of the insurance 
system.  
The innovative aspect of the new legislation is the abolition of the positive list and 
the establishment of a rebate system granting the National Insurance Funds a rebate rate 
paid by the pharmaceutical companies.17)  
8.2 Historical data 
The National Organization for Medicines (EOF) was established in 1983, with Act 
1316, and is a public entity of the Ministry of Health. 
 EOF mission is to ensure public health and safety with regard to the following 
products, marketed in Greece: 
 medicinal products for human and veterinary use 
 medicated animal foods and food additives 
 foodstuffs intended for particular nutritional uses and food supplements 
 biocides 
 medical devices 
 cosmetics 
Within the framework of its mission, EOF, in co-operation with the European 
Union, performs the following tasks: 
 Evaluates and authorizes new, safe and efficient health related products. 
 Monitors the post-marketing product quality, safety and efficiency. 
 Monitors product manufacturing procedures, clinical studies and the marketing of 
products, in order to ensure compliance with good manufacturing, laboratory and 
clinical practice, as well as with the existing legislation regarding the marketing, 
distribution, commercialization and advertising of the products. 
 Develops and promotes medical and pharmaceutical research. 
 Provides health scientists, competent authorities, and the general public with objective 
and useful information regarding medicines (for human or veterinary use) and other 
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“EOF is administered by a Management Board. Today's EOF structure was set in 
place by Presidential Decree (P.D.) 142/89. It has 9 divisions (see organization scheme 
attached). 
EOF achieves its objectives with the co-operation of 238 employees, which include 
80 pharmacists, chemists, physicians, biologists, and veterinarians as well as 26 
economists, mathematicians, lawyers and information scientists. It also co-operates with 
approximately 400 external health related scientists of various specialties. EOF has 45 
representatives that participate in committees and working groups of the European 
Union and Council of Europe and with the help of expert scientists, it has formed 24 
scientific committees and boards among which the most important are:  
 The Scientific Board of Approvals. States its opinion on the issue of authorizations, 
amendments, revocations, and suspensions of marketing authorizations for products 
under the authority of EOF. This board is composes of several divisions which 
encompass conventional medicinal products, biological medicinal products, blood 
products, radioactive medicinal products, special foods, veterinary medicinal products 
and veterinary vaccines.  
 Pharmacovigilance Committee. Evaluates the adverse drug reactions and makes 
suggestions on correcting or amending the Summaries of Products Characteristics 
(SPC's) and Patient Information Leaflets (PILs).  
 Scientific and Ethics Committee of Clinical Studies Authorization. Ensures the 
protection of the rights, safety and health of people who participate in clinical studies. 
 Pharmacopoeia Committee. Drafs the Hellenic Pharmacopoeia.  
National Formulary Committee. Is responsible for the elaboration of issues regarding 
the marketing of cosmetics.  
The Medical Devices Committee. Makes suggestions on the characterization of 
products as medical devices, their classification, the appointment and control of Notified 
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Bodies, and the specific regulations for the implementation of related legislation.  Second 
Degree Scientific Board. Revies appeals against initial EOF decisions”.17) 
CHAPTER 9: Pricing of drugs 
9.1 Definitions for pricing 
1. “Maximum Wholesale Price of Medicines” is the price at which medicinal 
products are sold to pharmacies. This price shall include the wholesale gross profit margin, 
calculated as a percentage on the net price of producer or importer.  
2. Maximum Retail Price of Medicines” is the price at which medicinal products 
are sold by pharmacies to consumers, and it is defined by the wholesale price, adding the  
lawful profit margin of the pharmacy the applicable and VAT. Maximum retail prices shall 
be uniform across the country. 
3. “Maximum Hospital Price of Medicines” is the price at which medicinal 
products  are sold by importers, manufacturers or packers to the State, public hospitals, 
social Care Units, EOPYY pharmacies. The maximum hospital price shall be determined 
on the basis of the wholesale price reduced by 13%. 
9.2 Pricing 
The Price Bulletin of Medicines for Human Use (including re-pricing, new generics 
and new original medicines) has been uploaded on the site of the Ministry of Health on 
Tuesday 06 August 2013.According to this, medicines for human use will be priced as 
following: 
 The wholesale price and the hospital price will be tax free. 
 The retail price includes tax and this tax is 6,5 %. 
Regarding the profit margins of pharmacies, these are:  
1. For wholesalers, gross profit margins shall be determined as follows:  
 for non-prescribed medicines (OTC), at 7.8% on the ex-factory price;  
 for prescribed medicinal products not reimbursed by social security agencies, at  5.4% 
on the ex-factory price;  
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 for medicinal products reimbursed by social security agencies, at 4.9% on the exfactory 
price; and  
 for the medicinal products of par. 2 of Article 12 of Law 3816/2010, at 2% on the   
hospital price. The resulting price shall hereinafter be referred to as “special  wholesale 
price”.  
2. for pharmacies, gross profit margins shall be determined as follows:  
 for non-prescribed medicines (OTC), at 35% on the wholesale price;  
 for prescription medicinal products not reimbursed by social security agencies, at  35% 
on the wholesale price;  
 for medicinal products reimbursed by social security agencies and having a  wholesale 
price of up to €200, at 32,4% on the wholesale price;  
 for reimbursed medicinal products having a wholesale price or a special wholesale  
price over €200, the profit margin of private pharmacies shall be equal to a fixed  
amount of €30.00.  
 for reimbursed medicinal products included in the list of par. 2 of Article 12 of Law  
3816/2010 and having a Special Wholesale Price of up to €200, the profit margin of  
private pharmacies shall be determined at 16% on the Special Wholesale Price. 
 
9.3 Unfair competition 
They are three article in the (FEK, 312 (16/9/92)) about the unfair competition in 
pharmacies. More specifically these are: 
Article 22 
Pharmacists must avoid attracting clients through actions and contrary to the 
dignity of man and the scientist in pharmacy and public health function (providing gifts or 
other compensation). 
Article 23 
Prohibited the pharmacist to replace with other drugs listed in a prescription , even 
if administered to replace the listed considered at the discretion of the larger and better 
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therapeutic value without the approval of the doctor who issued the prescription. 
Article 24 
Generally prohibited pharmacists pharmacy operation, beneficiaries inherited pharmacies 
and pharmacists responsible inherited pharmacies follows: 
a) Each drug sale at a price less than the prescribed retail price with vouchers Department 
of Commerce . 
b) Any contract, transaction or arrangement aimed at profiting at the expense of patients' 
health and any other person. 
 c) Any distribution or sharing with others the rate of profit pharmacist. 
d) Each of gifts or other benefits to doctors, dentists, midwives, nurses or other brokers to 
attract customers. 
e) Any violation of the opening hours of the pharmacy. 
f) Any exchange of money or other items of indicated prescription drug insurance fund. 
g) Any action that may procure an undue benefit to the customer. 
h) Each facility to anyone who employs illegal pharmaceutical science. 
i) Any agreement with any possibly employing , any health profession in order to reap 
benefits of the pharmacist and this agreed upon at the expense of the health of the patient 
and any other person . 
j) Any use honorific office held by the pharmacist to attract customers. 
k) Any contract with an insurance fund or legal persons providing pharmaceutical care 
with terms different from those who have accepted the P.F.S. and the pharmaceutical 
society of which he is a member of the pharmacist. (FEK, 312 (16/9/92)) 







10.1 Pharmaceutical policy 2009-2012 
It is a fact that in recent years and due to Memorandum, there have been done a 
number of changes which have changed significantly pharmaceutical policy , which 
followed hitherto in Greece 
A significant feature is the fact that only for the period under examination, ie 
1/1/2012 to 31/12/2013 has been three ministerial decisions which related to 
pharmaceutical policy. 
First of all, we will refer to the beginning of the reform on the pharmaceutical 
sector, which started in 2010, within the general framework of the Memorandum, which 
commanded the modernization and improvement of this sector. 
More specifically, the Law 3816/2010 introduced new drug lists (positive, negative 
, OTC and serious illness), to the separation of pharmaceuticals on the market with various 
technical criteria, so as to establish a different rate for state compensation in each drug 
according to the list belongs to. 
Moreover, in 2010 it started the attempt to set up a system of electronic prescription 
in an attempt to monitor and control better and more effectively the prescribing behavior of 
physicians and the pharmaceutical expenditure of social security institutions. 
Regarding the satisfaction with the implementation of electronic prescribing, we 
can say that this is satisfactory, since the end of 2012, 90 % of prescriptions were recorded 
in most electronics. (Foundation for Economic and Industrial Research, 2013) 
In addition, in 2011 are issued the Laws 3918 and 4025, which stipulated changes 
in profit rates wholesalers and extend the list of serious diseases medicines, industry 
discounts on hospital sales, a rebate for each prescription drug , each company had to trade 
EUR 4% of sales of this formulation and the so-called entry fee set equal to 4% of the 
producer price (ex-factory) and which will fall exclusively licensees medicinal 
preparations. 
 
Then after a brief reference to major changes in pharmaceutical policy, which occurred 
prior to the study period of this study , we come to 2012, where a variety of measures and 
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reforms in the health and drug introduced and implemented in the framework of the second 
program economic Adjustment. 
In particular, the adopted automatic return (claw back) to pharmaceutical 
companies. This measure provides that if the monthly public pharmaceutical expenditure 
of the social security exceeds the estimated cost of the excess amount will be recovered 
from marketing authorization holders of preparations, namely pharmaceutical companies. 
Moreover, it was given the opportunity to offset various requirements of FKA and 
hospitals with claims against pharmaceutical companies. In an effort that had began to hold 
public pharmaceutical expenditure from 2010 had highlighted the usefulness of increasing 
generic penetration. 
By N.4052/2012 became mandatory prescription under active substance, initially 
for ten active substances with the highest circulation and by June 2012, mandatory for all 
active substances. (Foundation for Economic and Industrial Research, 2013) 
Simultaneously with this measure promoted changes in pricing of generic drugs by 
establishing a new dynamic pricing system. (Foundation for Economic and Industrial 
Research, 2012) 
Also, this system provides that the first generic to be introduced to the market 
immediately after patent expiration of the original will have a default value which will not 
exceed 40 % of the original price just before the expiry of the patent , and for each 
following triad generic maximum allowable value will be 10 % lower than the first generic, 
or from the previous generic triad that had received approval for marketing . 
It should be noted that the same law included changes in margins both the 
wholesalers and pharmacists, which is now different for positive and negative drug list for 
wholesalers and different depending on the wholesale price of the drug to pharmacists. 
Accordingly, in October 2012, as per above, issued three ministerial decisions with 
new changes in the lists of drugs, the compensation scheme and margins of pharmacists. 
More specifically , for medicinal wholesale or special wholesale price of over € 200 profit 




Also, for drugs reimbursed by the state and under the list of drugs serious diseases 
N.3816/2010 profit pharmacists set at 16% of the special wholesale price. 
Moreover, under the interministerial decision of 104747, its sets up a list of medicines you 
with reduced participation of the patients and the completion of a list of drugs by the 
National Medicines Agency under the classification system anatomical therapeutic 
classification with ATC the estimated participation rate for each formulation. (Foundation 
for Economic and Industrial Research, 2013) 
More specifically, in October 2012 issued a ministerial decision of 104744, which 
sets up a positive list of medicines under ATC4, in which are introduced for the first time 
reference values . 
For the definition of the reference value of each medication on the list will take into 
account data on the efficacy, safety, quality, cost - effectiveness and wider socio-economic 
implications. 
The Reference Price of each therapeutic class is defined as the lowest cost Daily 
Therapy between the set of all reference drugs (with or without protection regime) and the 
average of the entire generic category. (Foundation for Economic and Industrial Research, 
2013). 
Based N.4093/2012, the automatic return will be calculated at 6-month basis and 
can no longer be offset against debts EOPYY or NHS hospitals to pharmaceutical 
companies . Also , the same law introduced payment by patients for each prescription 
performed by a pharmacist in the amount of one (1 ) euro and the payment of € 25 for each 
admission for treatment in NHS hospital , from 1.1 -2014 . 
Further, a restriction was that the percentage of the total annual value of 
prescription drug under the trade name of each physician not to exceed 15 %. 
In addition, the law 229A/19.11.2012 also provides for temporary fee equal to 15 % 
of sales of each formulation was in the positive list in 2011, with the possibility of clearing 
the automatic refund for the year 2012 . 
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The validity of this measure starts from 1-1-2013 and non- compliance of the 
marketing authorization holders of preparation will lead to automatic transfer of the 
preparation in the negative list of drugs. 
Moreover, the law 3035/15.11.2012 entered new limit public pharmaceutical 
expenditure for 2013 to € 2,44 bn Thus , an excess of the limit will trigger the automatic 
return mechanism. (Foundation for Economic and Industrial Research , 2013) 
10.2 Pharmaceutical interventions for the period 2013 – 2016 
In accordance with the provisions in the Memorandum between Greek government 
and the European Commission, ECB and IMF (December 2012) , will continue efforts to 
reduce public pharmaceutical expenditure , so that to reach 1% of GDP in 2014 . 
To achieve this goal it will make automatic return to pharmaceutical expenditure is 
kept within the budgeted limits , will further reduce the price of off-patent and generic 
pharmaceuticals , will reduce the average profit margin of pharmacies in 15 % , will reduce 
operating costs of hospitals , will raise contributions of farmers and revised service 
package that offers EOPYY . 
In particular, we have: 
A) Health System Governance 
 Direct purchase hospital services from EOPYY on a budget, based on costed 
procedures. 
 A 10% reduction in medical staff EOPYY until December 2012 and a further 10 % in 
2013. (Foundation for Economic and Industrial Research , 2013) 
B) Control of pharmaceutical expenditure 
Revision of the structure of contribution to the costs of buying medicines which 
will be excluded from participating small number of formulations related to specific 





 Downward revision of prices of drugs and medicines repricing with price less than € 
10, which includes reducing the price by 10 % . 
 Implementation of automatic return (clawback) every six months in an attempt to 
ensure that there are no deviations from the target. 
 Development Implementation Report on the impact of new margins of pharmacies, 
which shows that if not achieved the goal of the average pharmacy margin of 15%, 
resulting in a revision of the margin . 
 Ensure that EOPYY will negotiate a 5% discount through price - volume agreements 
on 200 drugs. 
 Extend the 5% discount from pharmaceutical companies on all products sold in 
pharmacies EOPYY. (Foundation for Economic and Industrial Research, 2013) 
D) Prescription 
 Extension of electronic prescribing in all doctors, medical centers and hospitals . 
 Implementation system of electronic submission of prescriptions pharmacists those not 
registered by doctors. 
  Version mandatory prescribing standards / protocols to doctors with priority for the 
most expensive and most widely used drugs . 
 Further development of a monitoring and control of electronic prescribing  
 Provide prior year's monthly reports on the use of electronic prescribing in the national 
health system and affiliated with EOPYY 
 Provide regular assessments of the information obtained from electronic prescriptions. 
 Prepare detailed quarterly reports on prescribing and pharmaceutical expenditure , 
which will include information on the volume and value of medications, use of 
generics and off-patent drugs and discounts received by pharmacies and 
pharmaceutical companies . 
 Production of detailed information and prepare reports for each physician prescribing 
behavior compared with the whole class (depending on the specialty and the number of 
patients) , which give signals violating prescriptions. 
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 A penalty when finding a breach of prescribing standards. 
  Select expensive drugs sold in pharmacies in order to be sold to hospitals or 
pharmacies EOPYY. (Foundation for Economic and Industrial Research , 2013) 
E) Increased use of generic 
 Increased use of generics to 35 % of the volume of drugs sold in pharmacies by the end 
of 2012 and 60 % by the end of 2013. 
 Additional measures will ensure that at least 50 % of the volume of medicines used in 
public hospitals is generic price lower than or similar branded off-patent products. 
 Determining liability in all public hospitals procure at least two thirds of 
pharmaceutical formulations based on the active substance , using centralized 
procedures requiring the submission of tenders and compliance with treatment 
protocols and prescribing guidelines . 
 Adoption in cooperation with pharmaceutical companies and physicians practices. 
(Foundation for Economic and Industrial Research, 2013) 
Chapter 11: Comparison of Pharmacies and Pharmacy Practice in 
Greece with Czech Republic 
 
It is fact that in Czech Republic have been many attempts in the direction of harmony with 
the European Transparency Directives. For this reason, competencies were transferred 
from Ministry of Health to the State authority for Drug Regulation. This change was set as 
a part of the Act about stabilization of public budgets, with effectiveness from 1st January 
2008. 
 
“More specifically, in 2007 government of Czech Republic issued an amendment 
about the Act on Public Health Insurance was prepared with the introduction of regulatory 
fees, limits on these fees per year and the introduction of generic substitution, with 
effectiveness from the beginning of 2008”. 
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“The new statutory text of the Act about Medicine was discussed in autumn 2007, 
during the approval process parliamentary amendments appeared which could negatively 
affect the development of pharmacy in the Czech Republic. Thanks to intensive work by 
the Chamber of Pharmacists and its cooperation with the state authorities it was managed 
to defend inevitable task of pharmaceutical care and possibility of further development”.
3)
 
“It is also worth noting that the amount of these changes and regulations were 
exposed to daily pharmaceutical practice, so the Chamber organized series of seminars 
during 2007, where the members were informed about all current and forthcoming 
changes. The start of new reforms 2008 were supported by the chamber too. The printed 
materials were published for patients with detailed and clear explanations of all new 
changes connected with regulation fees from the beginning of 2008”.
3)
 
As we see above, a similar situation exists in Greece, where in the field of 
Memorandum, the Greek government issued amendments in an attempt to be harmonized 
with the European directive about pharmacies and pharmacy policy. 
With the exception of non-prescription pharmaceutical products which are not 
subject to reimbursement, all pharmaceutical products in the Czech Republic are subject to 
price control. 
Regarding the prices and the profit margins, it is fact that manufacturers and 
importers submit their price proposals to the Ministry of Finance, which issues a List of 
Maximum Prices (based on a therapeutic reference pricing system).  
More specifically, “the prices of domestic products in Czech Republic are set on a 
basis of a maximum 30% pre-tax profit margin; regarding imported products, importers 
have to present their price lists and advise the Ministry of Finance on turnover and pre-tax 
profits. 
Different prices apply throughout the various trade channels. The margins applied 
to pharmaceutical products in the Czech Republic can be expressed in the following:  
 Wholesaler: eight digressive margin groups (which are cumulatively built up), starting 
with  a 36% maximum common margin for products cheaper than CZK 150 (€ 109) 
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and ending  with 5% for those above CZK 10,000 (€ 7280). A zero margin is also 
possible.  
 Pharmacist: the margin is calculated according to t he following formula, plus a 
dispensing fee of CZK 30 (€ 22) per item:  Regulatory fee (=CZK 30)*{0.25*[ARCTG 
(manufacturer selling price/50-2.5)+1.6]}  
 State (Value Added Tax - VAT): a discounted VAT of 10% on the wholesale price (the 
standard VAT rate is 20%)” (CBI market survey, 2010) 
If we compare this data with the data that we refer above regarding the profit 
margins in Greece, we can observe that in Greece the profit margins of wholesalers are 
significantly lower that Czech Republic. 
Also, we can point out that “the Czech Republic has a strong production of generic 
medicines, which was enhanced in 2003 by the merger of the country’s leading 
manufacturer, Leciva, with one of Slovakia’s leading pharmaceutical companies, 
Slovakofarma, to form Zentiva. In 2007, the company acquired Turkey’s Eczacibasi 
Generic Pharmaceuticals and boosted its sales growth. 
In spite of important mergers involving Czech companies, the Czech Republic’s 
pharmaceuticals industry is characterized by a high degree of foreign ownership, according 
to PriceWaterHouseCoopers.  
Pharmaceutical companies operating in the Czech Republic are subject to an 
extremely strict and complex regulatory environment. The Czech State Institute for Drug 
Control regulates every aspect of business, from pricing to packaging, from clinical trials 
to advertising.  
Production of branded pharmaceutical products in the Czech Republic is minimal, 
since they are easily obtainable from neighbouring countries such as Germany and Austria. 
In addition, the Czech Republic is forbidden by the EU’s accession treaty to 
parallel low-priced patented pharmaceutical products to high-price EU markets (e.g. 




On the other side, the situation is quite better in Greece, as the pharmaceutical 
production is quite average, while there are high margins of further development in the 
next years, in contrast to the existing situation in Czech Republic. 
Finally, the pharmaceutical policy under the Act No. 372/2011 Coll., refers that on 
health services for pharmaceutical care as care, whose purpose is the provision , 
preparation, treatment, storage, control and distribution of drugs, with the exception of 
blood products and raw materials for the production of blood derivatives according to the 
law on drugs, laboratory chemicals, reagents, disinfectants.  
Furthermore, the provision, storage, distribution and sale of medical is associated 
with the Medical Devices Act, together with the provision, storage, distribution and sale of 
food for special medical purposes and other services in the area of prevention and early 
detection of disease, health promotion.  
Likewise, the assessment and control of efficiency, the safe and economical use of 
medicines and procedures associated with it. 
About pharmacies, the law refers that are the most easily accessible medical 
facilities for the general public and often are the first point of contact of the patient in the 
health care delivery system.  
In addition, pharmacists specialize in a wide range of options, particularly with 
regard to the specific diagnosis or specific group of patients. Modern pharmaceutical care 
is an evolving set of activities, based on the professional level pharmacy staff, its unique 
identity and technology available. A prerequisite is coherent cooperation with physicians 
and other health care workers. (Act No. 372/2011 Coll)  
As we can observe the legislation about pharmacists and pharmacies in Greece and 
Czech Republic have many similarities, but the laws are modified to the field and the 
conditions of each country. 
Finally, we can refer that the main aim of Czech Champer of Pharmacists has many 
similarities with the EOF of Greece. More specifically, the main aims of Czech Champer 
of Pharmacists are: 
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 To pay for pharmaceutical care was provided by a multicomponent pharmacist was 
evaluated for contribution to ensuring the safety and effectiveness of drug therapy, and 
also to minimize the costs of payers and patients. 
 In order to clarify the conditions regulating the operation of public pharmacies, as well 
as demographic and geographic criteria for their establishment. 
 That responsibility for the management and operation of public pharmacies was the 
domain of pharmacists. 
 That the conditions have been established specialized education effectively and 
flexibly. 
  In order to pharmacists in relation to occupational motivated to engage in postgraduate 
education, lifelong learning and scientific research activities. 
 In order to identify the types and range of specialized pharmacists meet the demands of 
modern pharmaceutical care. 
 To have achieved specialization linked to competencies to specific professional 
activities, including links to the reimbursement system to deliver them. 
  To other sources of funding pharmaceutical care helped to further develop the 
pharmacy. 
  In order to provide support to all activities aimed at popularizing the pharmacy.  
Also, the laboratory activities are: 
 Ensuring the availability and safety of medicinal  
 Improving treatment outcomes of individual patients  
 Activities to promote public health  
 Increasing the efficiency of the health system 
Finally, the mission of pharmacists in Czech Republic is to promote public health goes far 
beyond the simple use of pharmaceuticals. It is part of a wider strategy to strengthen and improve 
public health. Attention is shifting from treatment to prevention. 
Due to the number and distribution of pharmacies is easily accessible for the vast majority 
of the population. Hits pharmacies are two times more frequent than visits to doctors' offices. The 
pharmacist has become a doctor with the largest number of contacts with the patient.  
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This puts pharmacies and their potential in a unique position to influence patients to 
improve public health, which has been repeatedly verified in both the Czech Republic and abroad. 
 Pharmacovigilance: Since pharmacists are expected to collect and report information 
about unexpected adverse reactions to the national authorities. This will help protect 
the health of patients and improve the quality of care. 
 Detection of emergency management for public health and crisis. 
Pharmacists are in a unique position to detect a risk to public health and played a 
vital role in national strategies for dealing with crisis situations. Pharmacy may be in crisis 
situations are readily adapted to provide information to citizens. 
 Dissemination of information for public health 
Availability pharmacies increases the effectiveness and reach of health campaigns 
and public health authorities allows targeted focus on specific issues such as the use of 
antibiotics and prevention of bacterial resistance, screening for cancer - melanoma, for 
example , stopping smoking , lifestyle changes, or nutritional advice. 
 Participation in the control and management of treatment in the early diagnosis 
and prevention of disease 
Pharmacies are equipped with instruments and devices that can measure and 
evaluate indicators still hidden disease. Early detection is especially in people who have 
not yet come into contact with other health care providers.  
When finding a revelation, outside the normal range or abnormalities that cannot be 
adjusted or normalized freely available drugs, the pharmacist is a health professional with 
the best scholarship to direct the patient to the doctor or specialist. Pharmacies are also an 
integral part of the programs of vaccination campaigns warning to the administration of the 
same vaccine. For the development of these services through special training of pharmacy 
employees. 
 Support for Self- Medication 
Pharmacists advice on medicines obtained without a prescription. It is essential for 
safe and effective self - treatment. Offer patients a wide range of services to address the 
health problems associated with obesity , smoking cessation and other addictions, sexual 
health and family planning , which is directly related to issuing emerging contraception. 
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 Safety and Environment 
Proper and safe disposal of unused or unusable drugs and medical devices is 
important for the environment and safety.  
Part of pharmacists, such as consultancy and implementation of these activities. 
The success of these activities depends on the proactive approach of state government. 
To the above directions the Czech Chamber of pharmacists attempts to:  
 To strengthen the involvement of pharmacists in support of public health is necessary  
 Encourage pharmacists to report adverse drug reactions. 
 Embed pharmaceutical information and communications technology solutions to the 
national e-Health system that can record pharmacists actively collect data related to 
public health through patient records medication. 
 Better use of pharmacies in a unique position to disseminate information in the field of 
public health. Moreover, public health authorities should make better use of the 
expertise of pharmacists, their communication skills and the availability of network 
pharmacies when preparing scenarios for crisis management in the field of public 
health. 
 To encourage and motivate pharmacists to develop screening programs, vaccination 
strategies and work with at-risk groups of patients. These activities are also 




In practice, there are not significant differences in the mission of pharmacists and 
the aims of EOF and Czech Chamber of pharmacists, as both countries make efforts to 
harmonize with the European directives regarding the pharmacies, pharmacists and the 





During the last decays in Greece, the pharmacist’s job shows an upward trend. 
According to statistics, the establishment of pharmacies has been rising sharply. As a 
result, nowadays, Greece has the largest number of pharmacies, per inhabitant, in all 
Europe. 
Picture 3: PHARMACIES IN EUROPE PER RESIDENTS
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COUNTRY PHARMACY POPULATION PHARMACY/POPULATION 
Greece 9.500 11.260.402 1.185 
Cyprus 434 796.875 1.836 
Malta 210 413.609 1.970 
Belgium 5.149 10.750.000 2.088 
Spain 21.057 45.828.172 2.176 
Lithuania 1.520 3.349.872 2.204 
Latvia 882 2.261.294 2.564 
Ireland 1.608 4.450.014 2.767 
Slovakia 1.931 5.412.254 2.803 
Estonia 474 1.340.415 2.828 
France 22.590 64.350.759 2.849 
Europe 141.582 470.517.730 3.323 
Italy 17.796 60.045.068 3.374 
Poland 10.628 38.115.641 3.586 
Germany 21.602 82.002.356 3.796 
Portugal 2.777 10.627.250 3.827 
Hungary 2.410 10.030.975 4.162 
Czech Republic 2.346 10.467.542 4.462 
United Kingdom 13.071 61.634.599 4.715 
Luxembourg 86 493.500 5.738 
Filandia 807 5.326.314 6.600 
Austria 1.233 8.355.260 6.776 
Slovenia 294 2.032.362 6.913 
Netherlands 1.976 16.405.399 8.302 
Sweden 883 9.256.347 10.483 
Denmark 318 5.511.451 17.332 
 
The approximately number of pharmacies in Greece, in 2012 was estimated at 
11,500.According to the law the ration between pharmacies and population is 1 pharmacy 
per 1000 residents.  
For example in Belgium (which has same population with Greece) the ratio is 1 
pharmacy per 6,000 residents. According to statistics in Belgium the average number of 
pharmacies is estimated at 6,000 while in Greece there are 12,000 nowadays. On the other 
hand, according to different source and specifically the table above (see picture 3), 
numbers don’t verify this fact.  
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Moreover it is calculated that city of Athens (calculated population:3,75 in 2012) 
has average number of pharmacies same, in comparison with whole Austria (calculated 
population:8,462 in 2012). Furthermore the percentage of pharmacists in Greece, has 
increased during the last decays(as you can see on picture 4 below). On a per capita basis, 
there are more than twice as many Greek pharmacists as French or Spanish ones, 74% 
more than in Bulgaria—Greece’s nearest competitor in druggist density—and an 
astonishing 17 times as many as in Denmark. 
 








As we said above, pharmaceutical industry is one of the significant sectors of the 
economy with many strategic benefits, which are identified either in the sense of mature 
capabilities either in the sense of good times and potential growth prospects. 
In this thesis has been described the Greek pharmaceutical legislation and the duties 
and responsibilities of pharmacists in Greece as compared to those in Czech Republic. It 
also focuses on the chambers of pharmacists and the reason they were organized.  
It is also worth noting that this thesis refers not only to community pharmacies, but 
also to hospital pharmacies and the way they work. 
The basic conclusion, which we can exact from our thesis, is the fact that both 
Greece and Czech Republic made significant efforts in latest years to harmonize their 
legislation to the European standards and directives. For this reason, both Czech 
government and Greek government issued many amendments in latest year, which aimed 
to this direction.  
However, a significant difference between Greece and Czech Republic is profit 
margins of wholesalers, which are higher in Czech Republic in comparison to Greece, 
while the production of drugs in Greece is significant higher than Czech Republic, which 
based more in its neighboring countries for the supply of drugs.  
Also, pharmaceutical companies, which are operating in the Czech Republic, are 
subject to an extremely strict and complex regulatory environment. The Czech State 
Institute for Drug Control regulates every aspect of business, from pricing to packaging, 
from clinical trials to advertising. 
Finally, there are not significant differences in the mission of pharmacists and the 
aims of EOF and Czech Chamber of pharmacists, as both countries make efforts to 
harmonize with the European directives regarding the pharmacies, pharmacists and the 
pharmaceutical policy in general. 
The general conclusion from this thesis is that the legislation about pharmacists and 
pharmacies in Greece and Czech Republic has many similarities, but the laws are modified 
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Aim of diploma thesis: The aim is to get current facts and knowledge about the situation 
of pharmacies in Greece, including their basic problems, and to compare it with the Czech 
Republic.  
Methods: Data collection through appreciation of information and studying of literature, 
esp. Greek legislation. 
Results: It was given necessary information on the National Health System in Greece and 
about place and role of pharmacies in this. The main part of thesis deals wits pharmacies in 
Greece (legislation, statistics, pharmacists, activities in pharmacy). There are many private 
community pharmacies and low amount of hospital pharmacies which are only for 
inpatients. 
Both Greece and Czech Republic made considerable efforts in latest years to harmonize 
their legislation to the European standards. However, a significant difference between 
Greece and Czech Republic is profit margins of wholesalers, which are higher in the Czech 
Republic in comparison to Greece, while the production of drugs in Greece is significant 
higher than Czech Republic, which based more in its neighboring countries for the supply 
of drugs.  
Conclusion: It has been described Greek pharmacies and the Greek pharmaceutical 
legislation for pharmacies, the duties and responsibilities of pharmacists in Greece as 
compared to those in the Czech Republic. It also focuses on the chambers of pharmacists 
and the reason they were organized. The basic EU legislation in field of pharmacy practice 
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Cíl práce: Cílem práce je získat aktuální fakta a znalosti o řeckých lékárnách, včetně 
základních problémů s nimi souvisejících, a porovnat se situací v této oblasti s Českou 
republikou.  
Metodika práce: Data byla získána studiem a porozuměním potřebné literatury a zvláště 
současné řecké legislativy. 
Výsledky: Byly poskytnuty základní informace o zdravotním systému v Řecku a o 
postavení a roli lékáren v něm. Hlavní část práce se zabývá lékárnami v Řecku (legislativa, 
statistika, lékárníci, činnosti v lékárně). V Řecku je velké množství soukromých veřejných 
lékáren a menší počet vládních nemocničních lékáren, které slouží pouze hospitalizovaným 
pacientům.  
V Řecku i v České republice je v posledních letech věnováno velké úsilí harmonizaci s 
legislativou Evropské unie. Rozdíl mezi Řeckem a Českou republikou je v zisku 
distributorů, který je v ČR vyšší. 
Závěr: Byly popsány řecké lékárny, řecká legislativa pro lékárny, povinnosti a 
odpovědnost lékárníků v Řecku a porovnána celková situace lékáren s Českou republikou. 
Pozornost byla věnována i komoře lékárníků a důvodům její existence. Základní legislative 
Evropské unie je závazná pro obě země. 
 
 
